Michael Mendelsohn
InvestorFounderInvestor at Broadview Ventures · Founder and Chief Strategy Officer at Cardurion
Boston, Massachusetts, United States
FoundedCardurion
Find your path to Michael
562 people in our graph share verified history with Michael — schools, employers, funds. One of them is your warm intro.
David SchenkeinunlockedMichael: together at Tufts Medical Center (2009–2010)
Michael: together at Foghorn Therapeutics, Inc
×4Michael: together at Harvard Medical School
Michael: together at Harvard Medical School; Brigham and Women's Hospital
About
Strategic Advisory Board member; Founder and Chairman of Cardurion Pharmaceuticals, cardiovascular physician-scientist and former Global Head of Cardiovascular Diseases at Merck.
Founder and Chief Strategy Officer at Cardurion
Intro paths
→
In turn, Michael can intro founders to Cardurion's investors below.
Cardurion's investors · 11
Ascenta CapitalWilmington · since 2024Bain CapitalBain Capital Life SciencesBoston · since 2024Bain Capital Tech OpportunitiesBoston · since 2024Delos CapitalCambridge · since 2024Digitalis VenturesNew York · $100K – $10M checks · since 2024Fidelity InvestmentsBoston · since 2024GV (Google Ventures)Mountain View · $250K – $50M checks · since 2024InvusNew York · since 2024Millennium ManagementNew York · since 2024New Enterprise Associates (NEA)Menlo Park · $200K – $40M checks · since 2024
Co-founders at Cardurion
MM
Michael Mendelsohn, M.D.Founder
Founder at Cardurion
Intro paths
→
In turn, Michael can intro founders to Cardurion's investors below.
Cardurion's investors · 11
Ascenta CapitalWilmington · since 2024Bain CapitalBain Capital Life SciencesBoston · since 2024Bain Capital Tech OpportunitiesBoston · since 2024Delos CapitalCambridge · since 2024Digitalis VenturesNew York · $100K – $10M checks · since 2024Fidelity InvestmentsBoston · since 2024GV (Google Ventures)Mountain View · $250K – $50M checks · since 2024InvusNew York · since 2024Millennium ManagementNew York · since 2024New Enterprise Associates (NEA)Menlo Park · $200K – $40M checks · since 2024
Co-founders at Cardurion
ME
Michael E. MendelsohnFounder and Chief Strategy Officer
Experience
- Cardurion PharmaceuticalsFounder and Chairmancurrent2016 — presentGreater Boston
- Foghorn Therapeutics, IncBoard Of Directorscurrent2016 — presentGreater Boston
- Mendelsohn Consulting Group LLCPresidentcurrent2013 — presentGreater Boston
- CyclerionBoard Of Directors2019 — 2023Greater Boston
- SV Life SciencesVenture Partner2014 — 2017Greater Boston
- Regado Biosciences-> Tobira Therapeutics (SAB member)Member of Board of Directors2013 — 2015
- Merck & CoSenior Vice President & Head, Atherosclerosis and Cardiovascular Research2010 — 2013
- Tufts Medical CenterChief Scientific Officer2008 — 2010
- Tufts Medical CenterExecutive Director, Molecular Cardiology Research Institute1998 — 2010
- Tufts UniversityElisa Kent Mendelsohn Professor of Molecular Cardiology and Medicine1998 — 2010
- Eon CorporationPresident and CEO1996 — 1998Boston, MA
- Harvard Medical School; Brigham and Women's HospitalAssistant Professor of Medicine; Cardiologist1982 — 1993
Skills & more
Cardiology45Senior Executive LeadershipMolecular & Cellular Biology4Medicine36Executive Management6Lifesciences22Drug Discovery34Clinical Trials30Early Development3Drug Design3Drug Development26Internal Medicine10
+12 more
Molecular PharmacologyCardiovascular PhysiologyHuman PhysiologyAcademic Medical Centersacademic medicinePharmaceutical IndustryBiomarkersNeurosciencePharmacologyClinical ResearchHypertensionClinical DevelopmentFrom Michael's professional profile.
Colleagues at Broadview Ventures
Annabel Chen-Tournoux
Investor at Broadview Ventures
Anubodh Sunny Varshney
Venture Advisor at Broadview Ventures
Benjamin Kreitman
Principal at Broadview Ventures
Christopher Colecchi
Managing Director at Broadview Ventures
Christopher de Souza
Director at Broadview Ventures
Daniel Gottlieb
Director at Broadview Ventures
David Milan
Chief Scientific Officer, Leducq Corp at Broadview Ventures
David Prim
Principal at Broadview Ventures
Frequently asked questions
- Who is Michael Mendelsohn?
- Strategic Advisory Board member; Founder and Chairman of Cardurion Pharmaceuticals, cardiovascular physician-scientist and former Global Head of Cardiovascular Diseases at Merck.
- Where does Michael Mendelsohn work?
- Michael Mendelsohn is Founder of Cardurion and at Broadview Ventures.
- What companies did Michael Mendelsohn found?
- Michael Mendelsohn founded Cardurion.
- Where did Michael Mendelsohn go to school?
- Michael Mendelsohn studied at Harvard Medical School (M.D., Medicine); Amherst College (B.A., Chemistry and English).
Founder mafias
Harvard Medical School mafia110
Also came through, then founded or led a company.
George ChurchFounded Editas Medicine +5Sangeeta N. BhatiaDoctor of Medicine (MD)Founded Port Therapeutics +3Andrey ZarurClinical ImmunologyFounded GreenLight Pandemic Response +3Howard ChangM.D.Founded Accent Therapeutics +3Michael TolentinoResidencyFounded Aviceda Therapeutics +2Venky SoundararajanResearch Fellowship in GeneticsFounded nference +2
+ 103 more
Amherst College mafia41
Also came through, then founded or led a company.
Jeffrey GlassBAFounded Hometap Equity Partners +1Mike GamsonB.A.Founded EvozyneWilliam FordBachelor of Arts - BAFounded General AtlanticJeffrey M. JonasBAFounded Sage TherapeuticsPhil EdmundsonB.S.Founded Corvus Insurance
+ 35 more
Same school
Also attended Harvard Medical School245
Niko BonatsosFounder and Managing Partner of VerdictAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital
.png)
+ 239 more
Shared employers
Also worked at Cardurion Pharmaceuticals2
Also worked at Foghorn Therapeutics, Inc3
Also worked at Cyclerion1
Also worked at Merck & Co153
Anika GuptaInvestor at GV (Google Ventures)Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Catherine Pearce, DHSc, MBAAdvisor at CincyTechDavid MollerInvestor at Third Rock VenturesAlan EzekowitzInvestor at Third Rock VenturesUri LopatinInvestor at Khosla Ventures
+ 147 more